A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma-Reference-Cited by-同舟云学术

A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma

Published:2017-04-25 Issue:3 Volume:178 Page:434-441
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Batlevi Connie L.¹,Crump Michael²,Andreadis Charalambos³,Rizzieri David⁴,Assouline Sarit E.⁵,Fox Susan⁶,van der Jagt Richard H. C.⁷,Copeland Amanda¹,Potvin Diane⁸,Chao Richard⁸,Younes Anas¹

Affiliation:

1. Lymphoma Service; Memorial Sloan-Kettering Cancer Center; New York NY USA

2. Princess Margaret Cancer Center; Toronto ON Canada

3. UCSF; Helen Diller Family Comprehensive Cancer Center; San Francisco CA USA

4. Duke University School of Medicine; Durham NC USA

5. McGill University; Montreal QC Canada

6. Charles LeMoyne Hospital; Greenfield Park QC Canada

7. University of Ottawa; Ottawa ON Canada

8. Mirati Therapeutics; San Diego CA USA

Funder

Mirati Therapeutics

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14698/fullpdf

Reference33 articles.

1. Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clones;Andersen;Leukemia Research Reports,2012

2. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project;Anderson;Annals of Oncology,1998

3. Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma;Assouline;Blood,2016

4. Acetylation inactivates the transcriptional repressor BCL6;Bereshchenko;Nature Genetics,2002

5. Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia;Blum;British Journal of Haematology,2009

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma;Leukemia;2024-08-08

2. Chidamide plus R‐GDP for relapsed/refractory diffuse large B‐cell lymphoma in patients ineligible for autologous transplantation: A prospective, single‐arm, phase II study;Cancer Medicine;2024-08

3. The novel combination of mocetinostat and capecitabine has a greater anti-tumoral effect on induced breast cancer in BALB/c mice;2024-05-21

4. Exome and targeted sequencing in clinical oncology- Diffuse large B-cell lymphoma as a model;Comprehensive Precision Medicine;2024

5. Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas;World Journal of Gastroenterology;2023-12-28